Straumann Holding AG stock (CH0012280076): Swiss dental specialist in focus as shares trade around mid-90s CHF range

Straumann Holding AG shares on SIX Swiss Exchange hovered in the mid-90s CHF range on 02/27/2026 as investors continued to digest the latest earnings and sector signals in the global dental market.

Straumann Holding AG shares remained in focus on the SIX Swiss Exchange as the stock traded in the mid-90s CHF range in late February 2026, reflecting ongoing investor assessment of the company’s growth prospects in the global dental implant and orthodontics market. According to MarketScreener price data for Straumann, the shares closed at 92.30 CHF on 02/27/2026 on SIX Swiss Exchange under the ticker STMN, after having opened the session near similar levels and moving within a relatively narrow intraday band.MarketScreener as of 02/27/2026

This closing level corresponded to a modest daily percentage change of -0.06 percent on 02/27/2026, with a reported trading volume of 64,054 shares for that session, suggesting moderate liquidity for the Swiss mid-cap healthcare name.MarketScreener as of 02/27/2026 The company is headquartered in Basel in Switzerland, and its primary listing on SIX Swiss Exchange anchors it firmly in the Swiss healthcare and medical technology universe for both domestic and international investors.

As of: 04/06/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: Straumann
• Sector/industry: Dental implants and orthodontic medical technology
• Headquarters/country: Basel, Switzerland
• Core markets: Europe, North America, Asia-Pacific
• Key revenue drivers: Dental implant systems, clear aligners, digital dentistry solutions
• Home exchange/listing venue: SIX Swiss Exchange (STMN)
• Trading currency: CHF

Straumann Holding AG: core business model

Straumann focuses on providing premium dental implant systems, orthodontic aligners and related digital workflows that support dentists and clinics in restorative and aesthetic dentistry, with revenue largely generated from equipment, consumables and services tied to dental implantology and orthodontic treatments.

Industry trends and competitive position

The broader dental market provides the setting in which Straumann Holding AG operates, and medium-term projections for specialized dental segments point to continued structural growth that underpins demand for the company’s solutions. According to an industry study on the dental regeneration market published by Coherent Market Insights, this niche of the dental sector is expected to reach forecasted revenue of USD 1,386.4 million in 2026 and could grow to around USD 2,437.9 million by 2033, implying a steady compound annual growth rate over that period as dental procedures become more widespread globally.Coherent Market Insights as of 2026

Within this expanding landscape, Straumann is positioned among leading players in dental implants and orthodontic solutions, competing with other international companies that supply implants, biomaterials and aligner systems to clinics and dental laboratories worldwide. The sector backdrop of aging populations, higher disposable incomes in emerging markets and a growing focus on aesthetic dentistry supports multi-year demand for advanced implant and tooth-replacement therapies, which in turn influences Straumann’s addressable market and investment appeal relative to global medical technology peers.

Conclusion

Straumann Holding AG’s recent trading levels around 92.30 CHF on SIX Swiss Exchange at the close on 02/27/2026 highlight how the market currently values the Swiss dental specialist amid a generally expanding global dental market. With industry studies pointing to sustained structural growth in areas such as dental regeneration, implants and related treatments through at least 2033, the company’s positioning in premium implantology and orthodontic solutions remains closely watched by investors. How Straumann executes on its strategic priorities in this environment, and how financial results compare with peers and sector trends, will remain central factors for the future development of the share price.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.